142 related articles for article (PubMed ID: 32875707)
1. Severe intellectual disability, absence of language, epilepsy, microcephaly and progressive cerebellar atrophy related to the recurrent de novo variant p.(P139L) of the CAMK2B gene: A case report and brief review.
Rizzi S; Spagnoli C; Salerno GG; Frattini D; Caraffi SG; Trimarchi G; Moratti C; Pascarella R; Garavelli L; Fusco C
Am J Med Genet A; 2020 Nov; 182(11):2675-2679. PubMed ID: 32875707
[TBL] [Abstract][Full Text] [Related]
2. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
[TBL] [Abstract][Full Text] [Related]
3. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
[TBL] [Abstract][Full Text] [Related]
4. A patient with novel MBOAT7 variant: The cerebellar atrophy is progressive and displays a peculiar neurometabolic profile.
Farnè M; Tedesco GM; Bedetti C; Mencarelli A; Rogaia D; Colavito D; Di Cara G; Stangoni G; Troiani S; Ferlini A; Prontera P
Am J Med Genet A; 2020 Oct; 182(10):2377-2383. PubMed ID: 32744787
[TBL] [Abstract][Full Text] [Related]
5. De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.
Küry S; van Woerden GM; Besnard T; Proietti Onori M; Latypova X; Towne MC; Cho MT; Prescott TE; Ploeg MA; Sanders S; Stessman HAF; Pujol A; Distel B; Robak LA; Bernstein JA; Denommé-Pichon AS; Lesca G; Sellars EA; Berg J; Carré W; Busk ØL; van Bon BWM; Waugh JL; Deardorff M; Hoganson GE; Bosanko KB; Johnson DS; Dabir T; Holla ØL; Sarkar A; Tveten K; de Bellescize J; Braathen GJ; Terhal PA; Grange DK; van Haeringen A; Lam C; Mirzaa G; Burton J; Bhoj EJ; Douglas J; Santani AB; Nesbitt AI; Helbig KL; Andrews MV; Begtrup A; Tang S; van Gassen KLI; Juusola J; Foss K; Enns GM; Moog U; Hinderhofer K; Paramasivam N; Lincoln S; Kusako BH; Lindenbaum P; Charpentier E; Nowak CB; Cherot E; Simonet T; Ruivenkamp CAL; Hahn S; Brownstein CA; Xia F; Schmitt S; Deb W; Bonneau D; Nizon M; Quinquis D; Chelly J; Rudolf G; Sanlaville D; Parent P; Gilbert-Dussardier B; Toutain A; Sutton VR; Thies J; Peart-Vissers LELM; Boisseau P; Vincent M; Grabrucker AM; Dubourg C; ; Tan WH; Verbeek NE; Granzow M; Santen GWE; Shendure J; Isidor B; Pasquier L; Redon R; Yang Y; State MW; Kleefstra T; Cogné B; ; ; Petrovski S; Retterer K; Eichler EE; Rosenfeld JA; Agrawal PB; Bézieau S; Odent S; Elgersma Y; Mercier S
Am J Hum Genet; 2017 Nov; 101(5):768-788. PubMed ID: 29100089
[TBL] [Abstract][Full Text] [Related]
6. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
Cai S; Li J; Wu Y; Jiang Y
J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
[TBL] [Abstract][Full Text] [Related]
7. Expanding the Phenotype of Homozygous
Yeşil G; Aralaşmak A; Akyüz E; İçağasıoğlu D; Uygur Şahin T; Bayram Y
Balkan Med J; 2018 Jul; 35(4):336-339. PubMed ID: 29545233
[TBL] [Abstract][Full Text] [Related]
8. Understanding the pathogenetic mechanisms underlying altered neuronal function associated with CAMK2B mutations.
Borghi R; Trivisano M; Specchio N; Tartaglia M; Compagnucci C
Neurosci Biobehav Rev; 2023 Sep; 152():105299. PubMed ID: 37391113
[TBL] [Abstract][Full Text] [Related]
9. A novel likely pathogenic heterozygous HECW2 missense variant in a family with variable expressivity of neurodevelopmental delay, hypotonia, and epileptiform EEG patterns.
Heide EC; Puk O; Biskup S; Krahn A; Rauf E; Kreilkamp BAK; Paulus W; Focke NK
Am J Med Genet A; 2021 Dec; 185(12):3838-3843. PubMed ID: 34327820
[TBL] [Abstract][Full Text] [Related]
10. A familial case of
Heiman P; Drewes S; Ghaloul-Gonzalez L
SAGE Open Med Case Rep; 2021; 9():2050313X21990982. PubMed ID: 33796307
[TBL] [Abstract][Full Text] [Related]
11. Deletion of a Single Lysine Residue at Position 292 of CAMK2A Disrupts Protein Function, Causing Severe Epileptic Encephalopathy and Intellectual Disability.
Lintas C; Facchiano A; Azzarà A; Cassano I; Tabolacci C; Galasso C; Gurrieri F
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510258
[TBL] [Abstract][Full Text] [Related]
12. Recurrent De Novo Mutations Disturbing the GTP/GDP Binding Pocket of RAB11B Cause Intellectual Disability and a Distinctive Brain Phenotype.
Lamers IJC; Reijnders MRF; Venselaar H; Kraus A; ; Jansen S; de Vries BBA; Houge G; Gradek GA; Seo J; Choi M; Chae JH; van der Burgt I; Pfundt R; Letteboer SJF; van Beersum SEC; Dusseljee S; Brunner HG; Doherty D; Kleefstra T; Roepman R
Am J Hum Genet; 2017 Nov; 101(5):824-832. PubMed ID: 29106825
[TBL] [Abstract][Full Text] [Related]
13. A potential gain-of-function variant of SLC9A6 leads to endosomal alkalinization and neuronal atrophy associated with Christianson Syndrome.
Ilie A; Gao AYL; Boucher A; Park J; Berghuis AM; Hoffer MJV; Hilhorst-Hofstee Y; McKinney RA; Orlowski J
Neurobiol Dis; 2019 Jan; 121():187-204. PubMed ID: 30296617
[TBL] [Abstract][Full Text] [Related]
14. Structural brain abnormalities in a single gene disorder associated with epilepsy, language impairment and intellectual disability.
Bathelt J; Astle D; Barnes J; Raymond FL; Baker K
Neuroimage Clin; 2016; 12():655-665. PubMed ID: 27747153
[TBL] [Abstract][Full Text] [Related]
15. A de novo mutation in RPL10 causes a rare X-linked ribosomopathy characterized by syndromic intellectual disability and epilepsy: A new case and review of the literature.
Bourque DK; Hartley T; Nikkel SM; Pohl D; Tétreault M; Kernohan KD; ; Dyment DA
Eur J Med Genet; 2018 Feb; 61(2):89-93. PubMed ID: 29066376
[TBL] [Abstract][Full Text] [Related]
16. Confirmation and Expansion of the Phenotype Associated with the Recurrent p.Val837Met Variant in TRPM3.
de Sainte Agathe JM; Van-Gils J; Lasseaux E; Arveiler B; Lacombe D; Pfirrmann C; Raclet V; Gaston L; Plaisant C; Aupy J; Trimouille A
Eur J Med Genet; 2020 Aug; 63(8):103942. PubMed ID: 32439617
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy.
Hamdan FF; Saitsu H; Nishiyama K; Gauthier J; Dobrzeniecka S; Spiegelman D; Lacaille JC; Décarie JC; Matsumoto N; Rouleau GA; Michaud JL
Eur J Hum Genet; 2012 Jul; 20(7):796-800. PubMed ID: 22258530
[TBL] [Abstract][Full Text] [Related]
18. The very low density lipoprotein receptor-associated pontocerebellar hypoplasia and dysmorphic features in three Turkish patients.
Sonmez FM; Gleeson JG; Celep F; Kul S
J Child Neurol; 2013 Mar; 28(3):379-83. PubMed ID: 22532556
[TBL] [Abstract][Full Text] [Related]
19. Survival of a male patient harboring CASK Arg27Ter mutation to adolescence.
Mukherjee K; Patel PA; Rajan DS; LaConte LEW; Srivastava S
Mol Genet Genomic Med; 2020 Oct; 8(10):e1426. PubMed ID: 32696595
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient.
Burglen L; Chantot-Bastaraud S; Garel C; Milh M; Touraine R; Zanni G; Petit F; Afenjar A; Goizet C; Barresi S; Coussement A; Ioos C; Lazaro L; Joriot S; Desguerre I; Lacombe D; des Portes V; Bertini E; Siffroi JP; de Villemeur TB; Rodriguez D
Orphanet J Rare Dis; 2012 Mar; 7():18. PubMed ID: 22452838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
